QQ客服 官方微博 反馈留言

	Reporting on Two Novel Fusions, DYSF-ALK and ITGAV-ALK, Coexisting in One Patient with Adenocarcinoma of Lung, Sensitive to Crizotinib
	Yin, J.; Zhang, Y.; Peng, F.; Lu, Y.
刊名	Journal of Thoracic Oncology
	2018
卷号	Vol.13 No.3页码:e33-e34
ISSN号	1556-0864
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1821277
专题	四川大学
作者单位	Department of Thoracic Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China
推荐引用方式 GB/T 7714	Yin, J.,Zhang, Y.,Peng, F.,et al. Reporting on Two Novel Fusions, DYSF-ALK and ITGAV-ALK, Coexisting in One Patient with Adenocarcinoma of Lung, Sensitive to Crizotinib[J]. Journal of Thoracic Oncology,2018,Vol.13 No.3:e33-e34.
APA	Yin, J.,Zhang, Y.,Peng, F.,&Lu, Y..(2018).Reporting on Two Novel Fusions, DYSF-ALK and ITGAV-ALK, Coexisting in One Patient with Adenocarcinoma of Lung, Sensitive to Crizotinib.Journal of Thoracic Oncology,Vol.13 No.3,e33-e34.
MLA	Yin, J.,et al."Reporting on Two Novel Fusions, DYSF-ALK and ITGAV-ALK, Coexisting in One Patient with Adenocarcinoma of Lung, Sensitive to Crizotinib".Journal of Thoracic Oncology Vol.13 No.3(2018):e33-e34.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。